Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Solid Biosciences Inc. (SLDB) had Return on Equity of -90.86% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-124.70M |
|
-- |
|
-- |
|
$129.73M |
|
$-129.73M |
|
$5.03M |
|
$-124.70M |
|
$-124.70M |
|
$-124.70M |
|
$-124.70M |
|
$-124.70M |
|
$-124.70M |
|
$-129.73M |
|
$-130.87M |
|
40.82M |
|
40.82M |
|
$-3.06 |
|
$-3.06 |
|
| Balance Sheet Financials | |
$157.30M |
|
$4.75M |
|
$31.36M |
|
$188.66M |
|
$30.26M |
|
-- |
|
$21.16M |
|
$51.42M |
|
$137.25M |
|
$137.25M |
|
$137.25M |
|
40.47M |
|
| Cash Flow Statement Financials | |
$-100.01M |
|
$-16.09M |
|
$122.44M |
|
$75.85M |
|
$82.19M |
|
$6.34M |
|
$10.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.20 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-100.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-90.86% |
-90.86% |
|
-66.10% |
|
-90.86% |
|
$3.39 |
|
$-2.47 |
|
$-2.45 |
|